Medical Cannabis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medical Cannabis stocks.

Recent Signals

Date Stock Signal Type
2021-05-14 ACB Gilligan's Island Buy Setup Bullish Swing Setup
2021-05-14 ACB Lower Bollinger Band Walk Weakness
2021-05-14 CGC NR7 Range Contraction
2021-05-14 CGC Lower Bollinger Band Walk Weakness
2021-05-14 CLVR Lower Bollinger Band Walk Weakness
2021-05-14 CLVR Narrow Range Bar Range Contraction
2021-05-14 CLVR NR7 Range Contraction
2021-05-14 CLVR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 HUGE NR7 Range Contraction
2021-05-14 HUGE Bollinger Band Squeeze Range Contraction
2021-05-14 HUGE Narrow Range Bar Range Contraction
2021-05-14 IGC Pocket Pivot Bullish Swing Setup
2021-05-14 IGC Stochastic Buy Signal Bullish
2021-05-14 IGC NR7 Range Contraction
2021-05-14 IMCC NR7 Range Contraction
2021-05-14 IMCC Lower Bollinger Band Walk Weakness
2021-05-14 MJ NR7 Range Contraction
2021-05-14 MJ Lower Bollinger Band Walk Weakness
2021-05-14 MJ Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-14 MJJ Stochastic Buy Signal Bullish
2021-05-14 MJJ Narrow Range Bar Range Contraction
2021-05-14 MJO Narrow Range Bar Range Contraction
2021-05-14 MJO Lower Bollinger Band Walk Weakness
2021-05-14 OGI NR7 Range Contraction
2021-05-14 OGI Stochastic Reached Oversold Weakness
2021-05-14 OGI Bollinger Band Squeeze Range Contraction
2021-05-14 TLRY Narrow Range Bar Range Contraction
2021-05-14 TLRY NR7 Range Contraction
2021-05-14 VFF Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 VFF Lower Bollinger Band Walk Weakness
2021-05-14 VFF 1,2,3 Retracement Bearish Bearish Swing Setup

Recent News for Medical Cannabis Stocks

Date Stock Title
May 16 TLRY Swiss Central Bank Bought Li Auto, XPeng, Zoom, and This Marijuana Stock
May 15 ACB Need To Know: The Consensus Just Cut Its Aurora Cannabis Inc. (TSE:ACB) Estimates For 2022
May 14 VFF Cannabis Stock Gainers And Losers From May 14, 2021
May 14 VFF The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
May 14 MJ The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
May 14 ACB The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
May 14 ACB Aurora to Participate in BMO Capital Markets Farm to Market Virtual Conference
May 14 MJ Meet MJUS: The New U.S. Cannabis ETF On The NYSE
May 14 ACB Aurora Cannabis Stock Is Sliding After Disappointing Results. What Wall Street Is Saying.
May 14 ACB Why Aurora Cannabis Stock Sank Friday
May 14 ACB Should Aurora Exit Recreational Market? Analysts Dissect Cannabis Co. Earnings
May 14 ACB Aurora Cannabis’ Q3 Loss Wider than Expected; Shares Plunge 10%
May 14 MJ ETFMG Launches Active US Marijuana ETF
May 14 TLRY Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?
May 14 TLRY Despite a Rough Week, Tilray Is Still a Better Investment Now Than a Year Ago
May 14 ACB Heron defended after yesterday's plunge, Aurora Cannabis earns mixed reactions after Q3 results - today's healthcare analyst action
May 14 ACB Aurora Cannabis Stock Falls Amid Losses In Q3, Announces Transfer To Nasdaq
May 14 ACB Aurora Cannabis Inc. (ACB) Q3 2021 Earnings Call Transcript
May 14 IGC India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
May 14 ACB Here's Just How Ugly Aurora Cannabis' Q3 Results Really Were

Medical cannabis, or medical marijuana, is cannabis and cannabinoids that are recommended by doctors for their patients. The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations. Limited evidence suggests that cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.Short-term use increases the risk of minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years in many cultures. A number of medical organizations have requested removal of cannabis from the list of Schedule I controlled substances, followed by regulatory and scientific review. Others oppose its legalization, such as the American Academy of Pediatrics.Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone. Countries that allow the medical use of whole-plant cannabis include Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay. In the United States, 33 states and the District of Columbia have legalized cannabis for medical purposes, beginning with the passage of California's Proposition 215 in 1996. Although cannabis remains prohibited for any use at the federal level, the Rohrabacher–Farr amendment was enacted in December 2014, limiting the ability of federal law to be enforced in states where medical cannabis has been legalized.

More about Medical Cannabis
Browse All Tags